Candoro ethics GmbH
DEM1202.HRB16199
Headquarters
Marie-Curie-Str. 11
61381 Friedrichsdorf
Hesse
Germany
Contact
Management
Andreas Christian Eberhorn
Managing Director
Since January 24, 2023
Andreas Christian Eberhorn
Managing Director
Since April 25, 2023
Hans-Georg Feldmeier
Managing Director
Since April 6, 2022
Hans-Georg Feldmeier
Managing Director
Since April 25, 2023
David Clifford PryceFormer
Managing Director
June 4, 2019 – January 31, 2020
Erik StorgaardFormer
Managing Director
October 10, 2019 – October 13, 2020
Franziska Ingeborg BezoldFormer
Managing Director
August 29, 2023 – October 30, 2023
Georg Sebastian RiedmayrFormer
Managing Director
May 18, 2021 – June 22, 2021
Mark Anthony Nicholas ZekulinFormer
Managing Director
August 27, 2019 – January 31, 2020
Michael A. PoppFormer
Managing Director
July 30, 2014 – June 4, 2019
Michael RödelFormer
Managing Director
July 30, 2014 – June 4, 2019
Paul Leopold StecklerFormer
Managing Director
October 10, 2019 – March 25, 2022
Phillip Stephen Trustee de Shaer Family Trust ShaerFormer
Managing Director
August 27, 2019 – January 31, 2020
Pierre Charles DebsFormer
Managing Director
June 4, 2019 – October 10, 2019
Silvia OttFormer
Managing Director
March 25, 2022 – January 24, 2023
Tejinder VirkFormer
Managing Director
June 4, 2019 – October 10, 2019
Trine Katborg DavidsenFormer
Managing Director
January 31, 2020 – March 25, 2022
Uwe BaumannFormer
Managing Director
March 11, 2016 – June 4, 2019
Financials
| Year | Revenue | Earnings | Balance Total | Equity Ratio |
|---|---|---|---|---|
| 2024 | ~72.000.000 € | -10.319.000 € | 23.688.000 € | 773.1% |
| 2023 | ~160.000.000 € | -2.907.900 € | 39.882.794 € | 77.4% |
| 2022 | ~160.000.000 € | -2.510.252 € | 46.713.912 € | 72.3% |
Industry
NACE 21.20Manufacture of pharmaceutical preparationsISIC 2100Manufacture of pharmaceuticals, medicinal chemical and botanical productsNAICS 325199Basic Chemical ManufacturingNAICS 325411Pharmaceutical and Medicine ManufacturingNAICS 325412Pharmaceutical and Medicine ManufacturingNAICS 325413Pharmaceutical and Medicine ManufacturingNAICS 325414Pharmaceutical and Medicine ManufacturingNAICS 339113Medical Equipment and Supplies ManufacturingUKSIC 21.20Manufacture of pharmaceutical preparationsNACE2025 21.20Manufacture of pharmaceutical preparations
Raw Data
{
"id": "8ed5ff33-3346-4546-827f-630bbd448ed7",
"euId": "DEM1202.HRB16199",
"name": "Candoro ethics GmbH",
"legalForm": "GmbH",
"status": "active",
"foundationDate": "2023-04-25T00:00:00",
"vatId": null,
"hq": {
"line2": null,
"street": "Marie-Curie-Str. 11",
"city": "Friedrichsdorf",
"zipCode": "61381",
"state": "HE",
"country": "DE",
"latitude": 50.2535036,
"longitude": 8.6600128
},
"contactData": {
"emails": [
"info@candoro.de"
],
"phones": [],
"websites": [],
"faxes": []
},
"managers": [
{
"name": "Andreas Christian Eberhorn",
"position": "Managing Director",
"startDate": "2023-01-24T00:00:00",
"endDate": null
},
{
"name": "Andreas Christian Eberhorn",
"position": "Managing Director",
"startDate": "2023-04-25T00:00:00",
"endDate": null
},
{
"name": "David Clifford Pryce",
"position": "Managing Director",
"startDate": "2019-06-04T00:00:00",
"endDate": "2020-01-31T00:00:00"
},
{
"name": "Erik Storgaard",
"position": "Managing Director",
"startDate": "2019-10-10T00:00:00",
"endDate": "2020-10-13T00:00:00"
},
{
"name": "Franziska Ingeborg Bezold",
"position": "Managing Director",
"startDate": "2023-08-29T00:00:00",
"endDate": "2023-10-30T00:00:00"
},
{
"name": "Georg Sebastian Riedmayr",
"position": "Managing Director",
"startDate": "2021-05-18T00:00:00",
"endDate": "2021-06-22T00:00:00"
},
{
"name": "Hans-Georg Feldmeier",
"position": "Managing Director",
"startDate": "2022-04-06T00:00:00",
"endDate": null
},
{
"name": "Hans-Georg Feldmeier",
"position": "Managing Director",
"startDate": "2023-04-25T00:00:00",
"endDate": null
},
{
"name": "Mark Anthony Nicholas Zekulin",
"position": "Managing Director",
"startDate": "2019-08-27T00:00:00",
"endDate": "2020-01-31T00:00:00"
},
{
"name": "Michael A. Popp",
"position": "Managing Director",
"startDate": "2014-07-30T00:00:00",
"endDate": "2019-06-04T00:00:00"
},
{
"name": "Michael Rödel",
"position": "Managing Director",
"startDate": "2014-07-30T00:00:00",
"endDate": "2019-06-04T00:00:00"
},
{
"name": "Paul Leopold Steckler",
"position": "Managing Director",
"startDate": "2019-10-10T00:00:00",
"endDate": "2022-03-25T00:00:00"
},
{
"name": "Phillip Stephen Trustee de Shaer Family Trust Shaer",
"position": "Managing Director",
"startDate": "2019-08-27T00:00:00",
"endDate": "2020-01-31T00:00:00"
},
{
"name": "Pierre Charles Debs",
"position": "Managing Director",
"startDate": "2019-06-04T00:00:00",
"endDate": "2019-10-10T00:00:00"
},
{
"name": "Silvia Ott",
"position": "Managing Director",
"startDate": "2022-03-25T00:00:00",
"endDate": "2023-01-24T00:00:00"
},
{
"name": "Tejinder Virk",
"position": "Managing Director",
"startDate": "2019-06-04T00:00:00",
"endDate": "2019-10-10T00:00:00"
},
{
"name": "Trine Katborg Davidsen",
"position": "Managing Director",
"startDate": "2020-01-31T00:00:00",
"endDate": "2022-03-25T00:00:00"
},
{
"name": "Uwe Baumann",
"position": "Managing Director",
"startDate": "2016-03-11T00:00:00",
"endDate": "2019-06-04T00:00:00"
}
],
"industry": {
"isic": [
"2100"
],
"nace": [
"21.20"
],
"nace2025": [
"21.20"
],
"naics": [
"325199",
"325411",
"325412",
"325413",
"325414",
"339113"
],
"uksic": [
"21.20"
],
"wz": []
},
"financials": [
{
"year": 2022,
"currency": "EUR",
"capital": 3183340,
"capitalIsEstimate": false,
"balanceTotal": 46713912.25,
"balanceTotalIsEstimate": false,
"earnings": -2510251.9,
"earningsIsEstimate": false,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 160000000,
"revenueIsEstimate": true,
"revenueCagr": 0,
"revenueCagrIsEstimate": false,
"returnOnSales": -1.5689074375,
"returnOnSalesIsEstimate": true,
"equity": 33769395.68,
"equityIsEstimate": false,
"equityRatio": 72.28980415786091,
"equityRatioIsEstimate": false,
"cash": 5527794.79,
"cashIsEstimate": false,
"receivables": 24480973.34,
"receivablesIsEstimate": false,
"liabilities": 12944516.57,
"liabilitiesIsEstimate": false
},
{
"year": 2023,
"currency": "EUR",
"capital": 3183340,
"capitalIsEstimate": false,
"balanceTotal": 39882794.13,
"balanceTotalIsEstimate": false,
"earnings": -2907899.65,
"earningsIsEstimate": false,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 160000000,
"revenueIsEstimate": true,
"revenueCagr": 0,
"revenueCagrIsEstimate": false,
"returnOnSales": -1.81743728125,
"returnOnSalesIsEstimate": true,
"equity": 30861496.03,
"equityIsEstimate": false,
"equityRatio": 77.38047622592686,
"equityRatioIsEstimate": false,
"cash": 0,
"cashIsEstimate": false,
"receivables": 25737055.4,
"receivablesIsEstimate": false,
"liabilities": 8568564.77,
"liabilitiesIsEstimate": false
},
{
"year": 2024,
"currency": "EUR",
"capital": 3183340,
"capitalIsEstimate": false,
"balanceTotal": 23688000,
"balanceTotalIsEstimate": false,
"earnings": -10319000,
"earningsIsEstimate": false,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 72000000,
"revenueIsEstimate": true,
"revenueCagr": -55.00000000000001,
"revenueCagrIsEstimate": true,
"returnOnSales": -14.331944444444444,
"returnOnSalesIsEstimate": true,
"equity": 183142000,
"equityIsEstimate": false,
"equityRatio": 773.1425194191152,
"equityRatioIsEstimate": false,
"cash": 0,
"cashIsEstimate": false,
"receivables": 6565000,
"receivablesIsEstimate": false,
"liabilities": 350000,
"liabilitiesIsEstimate": false
}
]
}